Repligen | RGEN - 营业费用

金融业

USD

USD 2.95B

现金及等价物

USD 566.02M

USD 94.08M

USD 1.14B

USD 135.83M

USD 542.21M

USD 19.97M

USD 39.54M

1.78K

EPS每股收益

USD 0.49

股本和储备

USD 2.11B

USD 103.83M

债务利息支出

USD 5.5M

USD 7.31M

USD 542.21M

USD 6.57B

USD 13.29M

USD 177.95M

USD 19.97M

普通股股本

USD 56.33M

164.06

USD 17.11M

USD 197.91M

销售和管理费用

USD 74.36M

USD 170.46M

贸易债权人

USD 30.01M

应收帐款人

USD 158.59M

	营业费用	更改		日
Agilent	USD 1.44B		27M	2025-12
Align Technology	USD 822.85M		11.8M	2025-12
Bio Techne	USD 241.42M		2.52M	2025-12
BioMarin Pharmaceutical	USD 676.18M		131.65M	2025-12
Bristol-Myers Squibb	USD 8.3B		10.25B	2025-12
Bruker	USD 900.9M		124.3M	2025-12
Charles River Laboratories	USD 918.41M		2.49B	2025-12
Danaher	USD 5.34B		45.74B	2025-12
Dentsply International	USD 423M		1.06B	2025-12
General Electric Aerospace	USD 10.94B		7.87B	2025-12
Henry Schein	USD 3.25B		110M	2025-12
Illumina	USD 903M		69M	2025-12
IQVIA Holdings	USD 1.69B		4.47B	2025-12
Mettler Toledo International	USD 777.8M		42.3M	2025-12
Myriad Genetics	USD 212.8M		16.2M	2025-12
OraSure Technologies	USD 40.35M		2.45M	2025-12
Pacific Biosciences Of California	USD 97.83M		41.29M	2025-12
Pfizer	USD 12.91B		79.89B	2025-12
Repligen	USD 177.94M		1.82M	2025-12
Revvity	USD 626.22M		25.62M	2025-12
Standard Biotools	USD 45.72M		2.7M	2025-12
Thermo Fisher Scientific	USD 9.91B		867M	2025-12
Waters	USD 661.85M		1.67B	2025-12
West Pharmaceutical Services	USD 642.5M		2.41B	2025-12